374 related articles for article (PubMed ID: 9416838)
41. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan.
Chen FM; Hou MF; Wang JY; Chen TC; Chen DC; Huang SY; Chung YS; Lin SR
Cancer Lett; 2004 Apr; 207(1):59-67. PubMed ID: 15050734
[TBL] [Abstract][Full Text] [Related]
42. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.
Kosaka T; Yatabe Y; Endoh H; Kuwano H; Takahashi T; Mitsudomi T
Cancer Res; 2004 Dec; 64(24):8919-23. PubMed ID: 15604253
[TBL] [Abstract][Full Text] [Related]
43. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT
Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816
[TBL] [Abstract][Full Text] [Related]
44. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer.
Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D
Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071
[TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer.
Powell B; Soong R; Iacopetta B; Seshadri R; Smith DR
Clin Cancer Res; 2000 Feb; 6(2):443-51. PubMed ID: 10690522
[TBL] [Abstract][Full Text] [Related]
46. The impact of p53 protein core domain structural alteration on ovarian cancer survival.
Rose SL; Robertson AD; Goodheart MJ; Smith BJ; DeYoung BR; Buller RE
Clin Cancer Res; 2003 Sep; 9(11):4139-44. PubMed ID: 14519637
[TBL] [Abstract][Full Text] [Related]
47. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China.
Hu N; Huang J; Emmert-Buck MR; Tang ZZ; Roth MJ; Wang C; Dawsey SM; Li G; Li WJ; Wang QH; Han XY; Ding T; Giffen C; Goldstein AM; Taylor PR
Clin Cancer Res; 2001 Apr; 7(4):883-91. PubMed ID: 11309337
[TBL] [Abstract][Full Text] [Related]
48. Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection.
Molleví DG; Serrano T; Ginestà MM; Valls J; Torras J; Navarro M; Ramos E; Germà JR; Jaurrieta E; Moreno V; Figueras J; Capellà G; Villanueva A
Carcinogenesis; 2007 Jun; 28(6):1241-6. PubMed ID: 17259658
[TBL] [Abstract][Full Text] [Related]
49. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.
Graziano SL; Tatum AH; Gonchoroff NJ; Newman NB; Kohman LJ
Clin Cancer Res; 1997 Jan; 3(1):87-93. PubMed ID: 9815542
[TBL] [Abstract][Full Text] [Related]
50. TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients.
Berns EM; Klijn JG; Smid M; van Staveren IL; Look MP; van Putten WL; Foekens JA
Genes Chromosomes Cancer; 1996 Jul; 16(3):170-9. PubMed ID: 8814449
[TBL] [Abstract][Full Text] [Related]
51. Relationship between TP53 tumour suppressor gene mutations and smoking-related bulky DNA adducts in a lung cancer study population from Hungary.
Anna L; Holmila R; Kovács K; Gyorffy E; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Husgafvel-Pursiainen K; Schoket B
Mutagenesis; 2009 Nov; 24(6):475-80. PubMed ID: 19643813
[TBL] [Abstract][Full Text] [Related]
52. Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer.
Hensel CH; Xiang RH; Sakaguchi AY; Naylor SL
Oncogene; 1991 Jun; 6(6):1067-71. PubMed ID: 1648702
[TBL] [Abstract][Full Text] [Related]
53. Mutational spectrum of the p53 gene in human small-cell lung cancer and relationship to clinicopathological data.
Lohmann D; Pütz B; Reich U; Böhm J; Präuer H; Höfler H
Am J Pathol; 1993 Mar; 142(3):907-15. PubMed ID: 8384408
[TBL] [Abstract][Full Text] [Related]
54. p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers.
Hartmann A; Blaszyk H; McGovern RM; Schroeder JJ; Cunningham J; De Vries EM; Kovach JS; Sommer SS
Oncogene; 1995 Feb; 10(4):681-8. PubMed ID: 7862445
[TBL] [Abstract][Full Text] [Related]
55. Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer.
Fong KM; Kida Y; Zimmerman PV; Ikenaga M; Smith PJ
Cancer Res; 1995 Oct; 55(19):4268-72. PubMed ID: 7671234
[TBL] [Abstract][Full Text] [Related]
56. Associations between polymorphisms in DNA repair genes and TP53 mutations in non-small cell lung cancer.
Cho S; Kim MJ; Choi YY; Yoo SS; Lee WK; Lee EJ; Jang EJ; Bae EY; Jin G; Jeon HS; Lee SY; Cha SI; Park TI; Kim CH; Park JY
Lung Cancer; 2011 Jul; 73(1):25-31. PubMed ID: 21129811
[TBL] [Abstract][Full Text] [Related]
57. A nonsense mutation (Arg-196-Term) in exon 6 of the human TP53 gene identified in small cell lung carcinoma.
Hayes VM; Oosthuizen CJ; Kotze MJ; Marx MP; Buys CH
Mol Cell Probes; 1996 Oct; 10(5):393-5. PubMed ID: 8910896
[TBL] [Abstract][Full Text] [Related]
58. High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors.
D'Amico D; Carbone D; Mitsudomi T; Nau M; Fedorko J; Russell E; Johnson B; Buchhagen D; Bodner S; Phelps R
Oncogene; 1992 Feb; 7(2):339-46. PubMed ID: 1312696
[TBL] [Abstract][Full Text] [Related]
59. p53 mutations in human lung tumors.
Miller CW; Simon K; Aslo A; Kok K; Yokota J; Buys CH; Terada M; Koeffler HP
Cancer Res; 1992 Apr; 52(7):1695-8. PubMed ID: 1312896
[TBL] [Abstract][Full Text] [Related]
60. Mutations in Keap1 are a potential prognostic factor in resected non-small cell lung cancer.
Takahashi T; Sonobe M; Menju T; Nakayama E; Mino N; Iwakiri S; Nagai S; Sato K; Miyahara R; Okubo K; Hirata T; Date H; Wada H
J Surg Oncol; 2010 May; 101(6):500-6. PubMed ID: 20213688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]